Centrul Medical Renasterea S.R.L.
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The Infectious Disease Department at Centrul Medical Renasterea S.R.L. is conducting studies centered on Clostridioides difficile infection. These trials seek to lower recurrence rates and enhance recovery by testing new antimicrobial strategies.
- Recurrence prevention approaches
- Evaluation of novel antibacterial agents
- Impact on patient quality of life
Based in Craiova, Romania, the hospital setting enables efficient enrollment and comprehensive care for participants affected by bacterial gut infections.
Virus Diseases
Ongoing research targets chronic hepatitis C virus and chronic hepatitis D virus infections. The studies compare innovative antiviral combinations with established therapies to achieve sustained viral response and reduce long‑term liver damage.
- Antiviral efficacy of new drug combinations
- Outcomes of treatment interruption strategies
- Comparative effectiveness versus standard regimens
With two dedicated investigators, the department contributes to regional efforts in managing viral hepatitis across Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Vedanta Biosciences Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Atea Pharmaceuticals Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrul Medical Renasterea S.R.L.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, placebo-controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis | Abivax | Phase III | Not Recruiting | Jun 2023 | Jun 2025 |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ruzasvir | 2 | Unknown | 2023-05-19 | 2025-10-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.